Literature DB >> 30111062

[Pharmacodynamics of Huanglian Jiedu decoction in Alzheimer's disease (AD) model rats and effect on improvement of inflammation microenvironment in brain].

Xin-Ru Gu1, Si-Yue Fang2, Wei Ren3, Hong-Jie Wang1, Jian Yang1, Nan Si1, Bao-Lin Bian1, Hai-Yu Zhao1.   

Abstract

To study the pharmacokinetics of active ingredients (alkaloids, iridoids and flavonoids) in Huanglian Jiedu decoction (HLJDD) in Alzheimer's disease (AD) model rats, and investigate its mechanism in treatment of AD. All of rats were divided into normal control group (n=6), shame operation group (n=6) and model group (n=12). Rats in shame operation group received daily subcutaneous injection of D-galactose (D-gal 50 mg·kg⁻¹) for a total of 45 d to induce subacute aging model. Based on the operation of shame operation group, the rats in model group were given with an injection of Aβ₂₅₋₃₅ (4.0 g·L⁻¹)-ibotenic acid (2.0 g·L⁻¹) into the nucleus basalis magnocellularis. Then rats in model group were divided into HLJDD one day administration group (n=6) and HLJDD one week group (n=6). The plasma concentration of alkaloids, iridoid and flavonoids was determined by liquid chromatography tandem mass spectrometry (LC-QQQ-MS) at different time points. The levels of seven inflammatory factors (MIP-2, IL-1β, IL-2, IL-8, IL-10, IL-13, TNF-α) in cerebrospinalfluid (CSF) were measured by Bio-Plex multi-factor detection technology. Iridoids in AD model rats, with high bioavailability, were easily absorbed and eliminated. The plasma concentration of alkaloid was lower, and the AUC (area under the curve) was higher in HLJDD one week group than that in HLJDD one day group. The plasma concentration-time curves of flavonoids showed obvious bimodal phenomena. After the gastric administration of HLJDD, the inflammatory factors in CSF of AD rats demonstrated a callback trend, including IL-1β/IL-10 (P<0.05) with significant difference. The pharmacokinetic behaviors of iridoids, alkaloids and flavonoids (41 compounds) in AD model rats were fundamentally elucidated, and HLJDD can improve the central inflammatory status of AD rats by regulating the levels of inflammatory factors. Copyright© by the Chinese Pharmaceutical Association.

Entities:  

Keywords:  Alzheimer's disease ; Huanglian Jiedu decoction(HLJDD) ; inflammatory cytokines ; pharmacokinetic

Mesh:

Substances:

Year:  2018        PMID: 30111062     DOI: 10.19540/j.cnki.cjcmm.2018.0092

Source DB:  PubMed          Journal:  Zhongguo Zhong Yao Za Zhi        ISSN: 1001-5302


  6 in total

1.  Antithrombotic effects of Huanglian Jiedu decoction in a rat model of ischaemia-reperfusion-induced cerebral stroke.

Authors:  Huan Liu; Xiaoyan Chen; Yanling Liu; Chunjuan Fang; Shaofen Chen
Journal:  Pharm Biol       Date:  2021-12       Impact factor: 3.503

2.  A Preliminary Inquiry Into the Potential Mechanism of Huang-Lian-Jie-Du Decoction in Treating Rheumatoid Arthritis via Network Pharmacology and Molecular Docking.

Authors:  Chenlu Li; Jingjing Pan; Chang Xu; Zhenlin Jin; Xupeng Chen
Journal:  Front Cell Dev Biol       Date:  2022-01-19

3.  Molecular mechanisms of Huanglian jiedu decoction on ulcerative colitis based on network pharmacology and molecular docking.

Authors:  Jing Yang; Chaotao Tang; Ruiri Jin; Bixia Liu; Peng Wang; Youxiang Chen; Chunyan Zeng
Journal:  Sci Rep       Date:  2022-04-01       Impact factor: 4.379

4.  Involvement of Huanglian Jiedu Decoction on Microglia with Abnormal Sphingolipid Metabolism in Alzheimer's Disease.

Authors:  Yi-Yu Qi; Xia Heng; Zeng-Ying Yao; Shu-Yue Qu; Ping-Yuan Ge; Xin Zhao; Sai-Jia Ni; Rui Guo; Nian-Yun Yang; Qi-Chun Zhang; Hua-Xu Zhu
Journal:  Drug Des Devel Ther       Date:  2022-03-30       Impact factor: 4.162

5.  Effects of Huang-Lian-Jie-Du Decoction on Oxidative Stress and AMPK-SIRT1 Pathway in Alzheimer's Disease Rat.

Authors:  Xinru Gu; Haiyu Zhao; Junyi Zhou; Yanyan Zhou; Xiaolu Wei; Hongjie Wang; Baolin Bian; Jian Yang; Wei Ren; Nan Si
Journal:  Evid Based Complement Alternat Med       Date:  2020-01-02       Impact factor: 2.629

Review 6.  Huang-Lian Jie-Du decoction: a review on phytochemical, pharmacological and pharmacokinetic investigations.

Authors:  Yiyu Qi; Qichun Zhang; Huaxu Zhu
Journal:  Chin Med       Date:  2019-12-18       Impact factor: 5.455

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.